Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests.

Washington, July 24 : A new research suggests that slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as 10,000 dollars per patient.

Many people with arthritis-related back pain might be prevented from getting long-lasting pain relief under the current management guidelines, US researchers said Friday.

LONDON (SHARECAST) - Anglo-Swedish drugs giant AstraZeneca said the US Food and Drug Administration (FDA) has approved VIMOVO, the pain relief pill for arthritis sufferers.

Do you have back pain? Believe it or not 8 out 10 people suffer from some sort of back pain. You are certainly not alone. Back pain can range from a dull, constant ache to a sudden sharp pain. In time you either grow used to the pain or you can find relief from the pain. There are a multitude of back pains, but in general there is acute back pain and chronic back pain. Acute back pain is usually a temporary condition with recovery periods in a few days to a few weeks. Chronic back pain, o